Tingxiu Xiang

15PUBLICATIONS
18CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 21, 2026
CRISPR technologies for detecting DNA and RNA methylation: Mechanisms, platforms, and translational opportunities.

|May 25, 2026
An HDAC4-specific PROTAC degrader achieves radiation sensitization by enhancing ferroptosis in lung cancer.

|Oct 29, 2025
Research on the Precise Differentiation of Pathological Subtypes of Non-Small Cell Lung Cancer Based on 18F-FDG PET/CT Radiomics Features.

Wenbo Li, Linjun Ju, Shuxian Zhang

|Jun 29, 2025
C1QL1 inhibits breast cancer through the HSP90α/VCP-ERS/UPR axis.

Ningning Zhang, Qing Shao, Xinni Xiang

|May 04, 2022
Disruption of ZNF334 promotes triple-negative breast carcinoma malignancy through the SFRP1/ Wnt/β-catenin signaling axis.

Zhaobo Cheng, Renjie Yu, Li Li

|Jan 20, 2022
ZBTB28 inhibits breast cancer by activating IFNAR and dual blocking CD24 and CD47 to enhance macrophages phagocytosis.

Li Li, Yijia Gong, Jun Tang

Pageof 3

Frequent Collaborators

3 joint publications

Kang Wang

2 joint publications

Guosheng Ren

1 joint publications

Jia-Zheng Sun

1 joint publications

Jiali Zheng